Allele dynamics plots for the study of evolutionary dynamics in viral populations.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3017622)

Published in Nucleic Acids Res on October 18, 2010

Authors

Lars Steinbrück1, Alice Carolyn McHardy

Author Affiliations

1: Max-Planck Research Group for Computational Genomics and Epidemiology, Max-Planck Institute for Informatics, Saarbrücken, Germany.

Articles citing this

The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol (2011) 1.48

Systems biology approaches to new vaccine development. Curr Opin Immunol (2011) 1.17

nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics (2015) 1.14

Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat Commun (2012) 1.12

Detecting patches of protein sites of influenza A viruses under positive selection. Mol Biol Evol (2012) 0.95

Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol (2014) 0.88

Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. Proc Natl Acad Sci U S A (2016) 0.84

Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol (2016) 0.83

Inference of genotype-phenotype relationships in the antigenic evolution of human influenza A (H3N2) viruses. PLoS Comput Biol (2012) 0.82

Components of selection in the evolution of the influenza virus: linkage effects beat inherent selection. PLoS Pathog (2012) 0.80

Evolution of 2009 H1N1 influenza viruses during the pandemic correlates with increased viral pathogenicity and transmissibility in the ferret model. Sci Rep (2016) 0.77

Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 viruses. Virus Evol (2016) 0.75

The maintenance of sex: Ronald Fisher meets the Red Queen. BMC Evol Biol (2013) 0.75

Articles cited by this

A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57

MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics (2001) 101.31

BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13

MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics (2004) 50.89

Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75

Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96

HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85

Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature (2005) 11.99

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99

Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34

The influenza virus resource at the National Center for Biotechnology Information. J Virol (2007) 11.33

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol (2005) 10.77

The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26

The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05

Unifying the epidemiological and evolutionary dynamics of pathogens. Science (2004) 8.33

Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science (2006) 7.12

Bayesian estimation of ancestral character states on phylogenies. Syst Biol (2004) 7.09

Predicting the evolution of human influenza A. Science (1999) 6.91

Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science (2006) 6.01

Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol (1990) 5.37

Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97

Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology (1991) 4.85

Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet (2009) 4.56

The evolution of epidemic influenza. Nat Rev Genet (2007) 4.12

Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A (2002) 4.02

Host species barriers to influenza virus infections. Science (2006) 3.94

The population genetics of dN/dS. PLoS Genet (2008) 3.88

The persistent legacy of the 1918 influenza virus. N Engl J Med (2009) 3.58

Historical perspective--Emergence of influenza A (H1N1) viruses. N Engl J Med (2009) 3.53

A statistical phylogeography of influenza A H5N1. Proc Natl Acad Sci U S A (2007) 2.91

Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A (2007) 2.67

Estimating diversification rates from phylogenetic information. Trends Ecol Evol (2007) 2.65

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56

Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog (2007) 2.52

Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci U S A (2003) 2.31

Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec (2010) 2.10

Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets (2007) 2.04

Recent changes among human influenza viruses. Virus Res (2004) 1.98

A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol (2008) 1.96

Reliabilities of identifying positive selection by the branch-site and the site-prediction methods. Proc Natl Acad Sci U S A (2009) 1.94

Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology (2005) 1.91

Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS One (2010) 1.75

Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics (2008) 1.47

Influenza: global surveillance for epidemic and pandemic variants. Eur J Epidemiol (1994) 1.46

Differentiation of two distinct clusters among currently circulating influenza A(H1N1)v viruses, March-September 2009. Euro Surveill (2009) 1.36

Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season. Wkly Epidemiol Rec (2004) 1.27

Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine (2007) 1.16

Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution. Genome Res (2007) 1.14

Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics (2009) 1.13

Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Wkly Epidemiol Rec (2005) 1.09

Recommended composition of influenza virus vaccines for use in the 2001-2002 season. Wkly Epidemiol Rec (2001) 1.01

Recommended composition of influenza virus vaccines for use in the 1999-2000 season. Wkly Epidemiol Rec (1999) 1.00

Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec (2008) 1.00

Use of antigenic cartography in vaccine seed strain selection. Avian Dis (2010) 1.00

Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Wkly Epidemiol Rec (2008) 0.94

Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season. Wkly Epidemiol Rec (2007) 0.92

Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season (northern hemisphere winter). Wkly Epidemiol Rec (2009) 0.92

Using a mutual information-based site transition network to map the genetic evolution of influenza A/H3N2 virus. Bioinformatics (2009) 0.90

Recommended composition of influenza virus vaccines for use in the 2005 influenza season. Wkly Epidemiol Rec (2004) 0.89

Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Wkly Epidemiol Rec (2003) 0.87

Recommended composition of influenza virus vaccines for use in 2000. Wkly Epidemiol Rec (1999) 0.85

Recommended composition of influenza virus vaccines for use in the 2008 influenza season. Wkly Epidemiol Rec (2007) 0.83

Recommended composition of influenza virus vaccines for use in the 2003 influenza season. Wkly Epidemiol Rec (2002) 0.83

Recommended composition of influenza virus vaccines for use in the 2006-2007 influenza season. Wkly Epidemiol Rec (2006) 0.83

Recommended composition of influenza virus vaccines for use in the 2004 influenza season. Wkly Epidemiol Rec (2003) 0.82

Recommended composition of influenza virus vaccines for use in the 2007 influenza season. Wkly Epidemiol Rec (2006) 0.81

Recommended composition of influenza virus vaccines for use in the 2002 influenza season. Wkly Epidemiol Rec (2001) 0.80

Recommended composition of influenza virus vaccines for use in the 2002-2003 season. Wkly Epidemiol Rec (2002) 0.79

Recommended composition of influenza virus vaccines for use in the 2006 influenza season. Wkly Epidemiol Rec (2005) 0.79

Recommended composition of influenza virus vaccines for use in the 2001 influenza season. Wkly Epidemiol Rec (2000) 0.76